GlobeNewswire Inc.··The Gross Law FirmCORT Faces Securities Lawsuit Over Relacorilant FDA Claims; April 21 Deadline Looms
Corcept Therapeutics ($CORT) faces securities lawsuit over alleged false FDA statements on relacorilant. Lead plaintiff deadline: April 21, 2026.
CORTshareholder lawsuitsecurities class action